These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2965205)

  • 61. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus.
    L'Héreault S; Barden N
    Brain Res Mol Brain Res; 1991 Mar; 9(4):327-32. PubMed ID: 1710012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons.
    Durham RA; Johnson JD; Eaton MJ; Moore KE; Lookingland KJ
    Eur J Pharmacol; 1998 Aug; 355(2-3):141-7. PubMed ID: 9760028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
    Trugman JM; James CL; Wooten GF
    Brain; 1991 Jun; 114 ( Pt 3)():1429-40. PubMed ID: 1829645
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antidepressants inhibit the glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons.
    Jackson IM; Luo LG
    J Investig Med; 1998 Dec; 46(9):470-4. PubMed ID: 9861783
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histamine-induced release of thyrotropin releasing hormone from hypothalamic slices.
    Charli JL; Joseph-Bravo P; Palacios JM; Kordon C
    Eur J Pharmacol; 1978 Dec; 52(3-4):401-3. PubMed ID: 103732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stimulation by gastrin-releasing peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro.
    Kabayama Y; Kato Y; Shimatsu A; Yanaihara N; Imura H
    Brain Res; 1986 May; 372(2):394-9. PubMed ID: 3085873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
    Millan MJ; Bervoets K; Mavridis M
    Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dopaminergic receptors in bovine retina and their interaction with thyrotropin-releasing hormone.
    Reading HW
    J Neurochem; 1983 Dec; 41(6):1587-95. PubMed ID: 6417273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brain thyrotropin-releasing hormone matures independently of the hypothalamus in the rat.
    Mori M; Kobayashi I; Wilber JF
    Horm Metab Res; 1985 Apr; 17(4):181-3. PubMed ID: 3924809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucocorticoids inhibit D1B, but not D2, receptor-mediated effects on hypothalamic atrial natriuretic factor neurons.
    Lee D; Huang W; Copolov DL; Lim AT
    Endocrinology; 1995 Dec; 136(12):5570-6. PubMed ID: 7588310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alterations in levels of thyrotrophin releasing hormone and rates of hormone degradation in hypothalamic tissue of the developing rat.
    Pease K; Shen H; Acres GS; Rupnow JH; Dixon JE
    J Endocrinol; 1980 Apr; 85(1):55-61. PubMed ID: 6771355
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction between thyrotrophin-releasing hormone and the muscarinic cholinergic system in rat brain.
    Garcia SI; Dabsys SM; Santajuliana D; Delorenzi A; Finkielman S; Nahmod VE; Pirola CJ
    J Endocrinol; 1992 Aug; 134(2):215-9. PubMed ID: 1402531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies on the nature of mammalian hypothalamic thyrotrophin releasing hormone using immunochemical, chromatographic and enzymic techniques.
    Jeffcoate SL; White N
    J Endocrinol; 1975 Apr; 65(1):83-90. PubMed ID: 806647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human fetal hypothalamic GnRH neurosecretion: dopaminergic regulation in vitro.
    Rasmussen DD; Liu JH; Swartz WH; Tueros VS; Yen SS
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):127-32. PubMed ID: 3539416
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurotensin perfusion of rat hypothalamus: dissociation of dopamine release from body temperature change.
    Myers RD; Lee TF
    Neuroscience; 1984 May; 12(1):241-53. PubMed ID: 6462447
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The effect of the dopamine D2 receptor agonist cabergoline on the content of catecholamines and expression of BDNF mRNA in the rat midbrain and hypothalamus].
    Anokhin PK; Veretinskaya AG; Pavshintsev VV; Shamakina IY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):54-59. PubMed ID: 31851173
    [TBL] [Abstract][Full Text] [Related]  

  • 80. D-1 and D-2 dopaminergic receptors regulate protein phosphorylation in the rat neurohypophysis.
    Treiman M; Greengard P
    Neuroscience; 1985 Jul; 15(3):713-22. PubMed ID: 2415870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.